New York, USA, April 22, 2025 (GLOBE NEWSWIRE) -- Parkinson’s Disease Therapeutic Domain Projected to See Transformational Growth Across the 7MM During the Study Period (2020–2034 ...

Summary: Rasagiline is a novel, investigational propargylamine that irreversibly and selectively inhibits monoamine oxidase type B (MAO-B ... in patients with early Parkinson's disease (PD ...

Before I got the new medication through the pump. I was taking two pills every two hours,” Scheffler said. It’s a struggle for many patients with Parkinson’s — constantly watching the ...